Emma Court voor Business Insider
do. 5 sep. ’19

We got an inside look at how the biotech Spark used mazes to develop a first-of-its-kind treatment for eye disease on the way to selling itself for $4.8 billion

The biotech Spark Therapeutics needed a way to measure improvements to a patient’s quality of life when testing a new treatment for a rare eye disorder. So Spark created a maze-like course, which included simulated obstacles like holes and grass, for…


Blijf op de hoogte van alle publicaties van deze auteur

versie master.616dec1 · production modus · 12 dagen geleden uitgebracht